Navigation Links
Tramiprosate (Alzhemed? preclinical results published in Neurobiology of Aging

vely.
  • Tramiprosate (Alzhemed? crosses the blood-brain-barrier to exert its activity with low toxicity in various animal species that were tested.
  • The presence of amyloid in the brain is one of the major histopathological characteristics of AD. The amyloid cascade hypothesis proposes that certain forms of Aβ peptide are toxic and causally related to the severity of AD. The Aβ-peptide is one of the most promising targets for the development of AD therapies.

    "This scientific paper highlights the potential benefits of Alzhemed?" said Dr. Andreas Orfanos, Neurochem's Executive Vice President, Strategic Planning and Scientific Affairs. "These preclinical results indicate that AlzhemedTM binds preferentially to soluble amyloid β peptide, interferes with the amyloid cascade and reduces the associated toxicity. Accordingly, this product candidate is shown to impede key detrimental events normally associated with Alzheimer's disease and which are believed to lead to severe consequences in the brain of the affected individuals."

    About tramiprosate (Alzhemed?
    Tramiprosate (Alzhemed? is a small, orally-administered molecule known as an amyloid β antagonist, designed to cross the blood-brain-barrier, bind to soluble Aβ peptide and interfere with the amyloid cascade, thereby leading to the prevention or inhibition of amyloid deposition and the toxic effects of Aβ peptide in the brain.

    About the Phase III Clinical Trials for tramiprosate (Alzhemed?
    Neurochem is currently conducting a multi-center, randomized, double-blind, placebo-controlled and parallel-designed, 18-month Phase III clinical trial in 1,052 mild-to-moderate AD patients which is being carried out at close to 70 clinical sites across the United States and Canada. To date, 600 patients have already completed 12 months on study medication and the trial is scheduled to be completed by January 2007. All patients who complete the
    '"/>

    Source:Neurochem, Inc.


    Page: 1 2 3

    Related biology news :

    1. Fatty spheres loaded with siRNA shrink ovarian cancer tumors in preclinical trial
    2. Dual gene therapy suppresses lung cancer in preclinical test
    3. Gene vaccine for Alzheimers disease shows promising results
    4. Roche clinical trial registry and results database launched
    5. Diabetic nerve therapy shows striking results
    6. Neurologix announces positive results of gene therapy clinical trial in Parkinsons disease
    7. New results validating Pall prion reduction filter disclosed at ISBT Congress
    8. Combination therapy shows promising results in patients with advanced lung cancer
    9. Vaccine for brain tumors shows promising results
    10. Artificial cornea offers better results for infants, some blind patients
    11. Encouraging results in pancreatic cancer research
    Post Your Comments:
    (Date:12/19/2014)... Dec. 18, 2014   LaunchKey , the first ... post-password and Internet of Things era, today announced the ... venture round was led by Metamorphic Ventures with participation ... Partners, VegasTechFund, and others.  LaunchKey has raised $4 million ... expand its team and bring LaunchKey to market in ...
    (Date:12/17/2014)... -- Valencell, a leader in performance biometric data sensor ... leaders such as Intel, Jabra, Atlas, and Scosche to ... These products will be showcased at CES 2015, taking ... . "Our partners choose PerformTek biometrics, ... with the clinical data to back it up," said ...
    (Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research ... http://photos.prnewswire.com/prnh/20130307/600769 ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) ... Market in the APAC Region 2015-2019"  report to ... emerging in this market is advances in technology. ... to upgrade biometric solutions to the latest standard ...
    Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
    ... infection is highly complex, research to understand how people ... occur in simpler organisms. Zebrafish are becoming an important ... maintained and manipulated and many fundamental processes between zebrafish ... embryo is highly amenable to drug screening assays. The ...
    ... Medical Center scientists have won prestigious National Institutes of ... Reya, Ph.D., an associate professor of pharmacology and cancer ... Michel Bagnat, Ph.D., assistant professor of cell biology, won ... of the 18 Pioneer Awards provides $2.5 million in ...
    ... BOSTON (9-24-09) -- The National Institutes of Health ... team led by Boston University biomedical engineer Bela Suki ... cell function, with the goal of understanding the possible ... diseases, metabolic disorders, aging and cancer. NIH today ...
    Cached Biology News:Fish fend off invading germs with an initial response similar to the one found in people 2Duke biomedical scientists win 2 highly prized NIH Director's Awards 2Boston University engineer to use $2.5 million NIH grant to cells' reaction to physical force 2
    (Date:12/22/2014)... Dec. 22, 2014  ( www.competitivehealth.com ) — Competitive ... medical bill review and advocacy service, has signed an ... WellCard Savings discount health services marketplace. 63% ... more than they expected to pay. As part of ... costs, WellCard Savings is pleased to offer medical bill ...
    (Date:12/22/2014)... 22, 2014 Fertility Associates of Memphis ... Bank USA , a network of more than 20 ... partnership, patients have fast access to a national pool ... IVF . Fertility Associates of Memphis is the only ... treatment option. , Dr. William Kutteh , director ...
    (Date:12/19/2014)... BioPlus Specialty Pharmacy (BioPlus), one ... of Nick Maroulis, Pharm.D. to the newly created position ... In this position, Dr. Maroulis will continue to manage ... of our multi-site pharmacies as the company expands. Dr. ... that time he has served in many different capacities ...
    (Date:12/19/2014)... Dec. 19, 2014 Bina Technologies, Inc. (Bina, ... that they have been acquired by Roche (SIX: RO, ... privately held company that provides a big data platform ... (NGS) data for the academic and translational research markets. ... and will continue to focus on development of their ...
    Breaking Biology Technology:WellCard Savings Announces CoPatient Medical Bill Review Service for Members 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 2Fertility Associates of Memphis Announces Partnership with Donor Egg Bank USA 3BioPlus Specialty Pharmacy Promotes Dr. Nick Maroulis to Vice President of Specialty Pharmacy Services 2Bina Technologies is acquired by Roche. 2Bina Technologies is acquired by Roche. 3
    ... -- Pioneer Surgical Technology, Inc. is pleased to announce that ... feasibility study patients was presented at the recent 10th annual meeting of ... New Orleans by Domagoj Coric , M.D., Chief, Department of ... , , ...
    ... , June 1 /PRNewswire-Asia-FirstCall/ -- Yongye International, Inc.,(Nasdaq: YONG ... brand plant and animal nutrient products in, China , today announced that ... Company, in,cooperation with the central government of Inner Mongolia Autonomous Region,hosted the ... , , ...
    ... The ... its curriculum. The online drug safety training courses from BioSoteria will form the ... students, postdoctoral fellows, and residents via the University of Maryland’s Blackboard system. ... Baltimore, MD and ...
    Cached Biology Technology:Two-Year Follow up Data of NuBac® IDE Feasibility Study Was Presented at SAS Meeting 2Yongye International Hosts Official NASDAQ Visit to Inner Mongolia 2Yongye International Hosts Official NASDAQ Visit to Inner Mongolia 3Yongye International Hosts Official NASDAQ Visit to Inner Mongolia 4University of Maryland School of Pharmacy Adopts BioSoteria's eLearning Drug Safety Courses 2University of Maryland School of Pharmacy Adopts BioSoteria's eLearning Drug Safety Courses 3University of Maryland School of Pharmacy Adopts BioSoteria's eLearning Drug Safety Courses 4
    Whole blood is collected from canines (any breed, either sex), refrigerated within 6 hours, processed within 24 hours and frozen at -20C....
    acridine orange 10-nonyl bromide (nonyl acridine orange)...
    anti-dansyl, rabbit IgG fraction *1 mg/mL* Secondary Detection; Anti-Dye and Anti-Hapten Antibodies...
    Because it is manufactured at our ISO 9001–certified facilities in Eugene, Oregon, we can guarantee that FluoroPure grade propidium iodide is greater than or equal to 98% pure by HPLC....
    Biology Products: